These Deals Strengthen Our Portfolio: Novartis CEO

These Deals Strengthen Our Portfolio: Novartis CEO Play

April 22 (Bloomberg) –- In a First on Bloomberg Interview, Novartis CEO Joe Jimenez discusses his company’s deals to buy Glaxo’s cancer-drug assets for $16B while selling it’s animal-health operation to Eli Lilly for $5.4B in an overhaul of the company. He speaks to Anna Edwards and Mark Barton on Bloomberg Television’s “Countdown.” (Source: Bloomberg)

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    Countdown

blog comments powered by Disqus